Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enze Bian

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Plant Science|May 4, 2018
Transcriptome-Wide Annotation of m<sup>5</sup>C RNA Modifications Using Machine LearningJie Song, Jingjing Zhai, Enze Bian, et al.
Frontiers in Plant Science|December 18, 2018
Corrigendum: Transcriptome-Wide Annotation of m<sup>5</sup>C RNA Modifications Using Machine LearningJie Song, Jingjing Zhai, Enze Bian, et al.
Toxicology and Applied Pharmacology|December 17, 2021
Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5Yizhen Tian, Weihu Yang, Ruiying Yang, et al.
BMC Biotechnology|July 2, 2025
An engineered hypoxia-response promoter for human umbilical cord-derived mesenchymal stem cell-based therapeuticsSong Yang, Weizhong Zhuang, Lishi Zhou, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Plant Science|May 4, 2018
Transcriptome-Wide Annotation of m<sup>5</sup>C RNA Modifications Using Machine LearningJie Song, Jingjing Zhai, Enze Bian, et al.
Frontiers in Plant Science|December 18, 2018
Corrigendum: Transcriptome-Wide Annotation of m<sup>5</sup>C RNA Modifications Using Machine LearningJie Song, Jingjing Zhai, Enze Bian, et al.
Toxicology and Applied Pharmacology|December 17, 2021
Ribavirin inhibits the growth and ascites formation of hepatocellular carcinoma through downregulation of type I CARM1 and type II PRMT5Yizhen Tian, Weihu Yang, Ruiying Yang, et al.
BMC Biotechnology|July 2, 2025
An engineered hypoxia-response promoter for human umbilical cord-derived mesenchymal stem cell-based therapeuticsSong Yang, Weizhong Zhuang, Lishi Zhou, et al.
Pageof 1